过去一年中添加的文章,按日期排序

Real-World Effectiveness of Nirsevimab Against Respiratory Syncytial Virus: A Test-Negative Case-Control Study

H Xu, C Aparicio, A Wats, BL Araujo, VE Pitzer… - medRxiv, 2024 - medrxiv.org
9 天前 - … This study confirms that nirsevimab is highly effective at preventing RSV-associated
outpatient visits, hospitalizations, and severe disease requiring ICU admission or high-flow …

Economic burden of respiratory syncytial virus in adults in Germany–a health claims analysis between 2015 and 2018

B Huebbe, A Mocek, KC Manz, A Vivirito… - Journal of Medical …, 2024 - Taylor & Francis
46 天前 - assess hospital and outpatient healthcare resource utilization (HRU) and costs of
RSV … Our assessment considered both RSV-specific and RSV-possible cases to account for …

Downloaded from https://academic. oup. com/ofid/article/10/Supplement_2/ofad500. 2240/7447701 by guest on 05 December 2023

DD Garofalo, S Toussi - pdfs.semanticscholar.org
98 天前 - … Most RSV outcomes occurred within 14 days of a positive test. Despite healthcare
… after RSV infection diagnosed in the outpatient setting, especially among infants < 1 year. …

Pulmonary Findings in MIRAGE Syndrome

N Lopez Valdez… - B63 …, 2024 - atsjournals.org
143 天前 - … , mild left mainstem bronchomalacia, and purulent bronchitis. Due to the patient’s
severe … clearance regimen that was adjusted during outpatient clinic visits. We performed a …

[HTML][HTML] Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023

AZ Blatt, M Suh, EB Walter, CT Wood, C Espinosa… - Annals of …, 2024 - Elsevier
147 天前 - … study suggest that infant RSV bronchiolitis cases continue to be under-estimated
in outpatient settings (Fig. 3, Fig. 4). Whether disproportionately low outpatient RSV testing will …

CROCuS, a Phase II Study Evaluating the Antiviral Activity, Clinical Outcomes, and Safety of Rilematovir in Children Aged≥ 28 Days and≤ 3 Years with Acute …

F Ferrero, CY Lin, J Liese, K Luz, T Stoeva, A Nemeth… - Pediatric Drugs, 2024 - Springer
152 天前 - … to assess the severity of RSV infections in children [19, 20]. … Meanwhile, RSV signs
and symptoms (assessed using … 1] or outpatient encounters during the study) were assessed

Effectiveness of nirsevimab against RSV-bronchiolitis in paediatric ambulatory care: a test-negative case–control study

Y Lassoued, C Levy, A Werner, Z Assad… - The Lancet Regional …, 2024 - thelancet.com
156 天前 - … We included 883 outpatients who had bronchiolitis and results of an RSV rapid
antigen test (453 were case patients, and 430 were control patients). Overall, 62/453 (13.7%) …

Assessing the Burden of Respiratory Syncytial Virus-related Bronchiolitis in Primary Care and at 15-Day and 6-Month Follow-up Before Prophylaxis in France: A Test …

A Rybak, R Cohen, M Bangert, R Kramer… - The Pediatric …, 2024 - journals.lww.com
159 天前 - … diseases using rapid antigen detection tests in outpatient children. We aimed to
assess the burden of RSV-related bronchiolitis compared to RSV-negative cases at 15 days …

CO103 Modelled Impact of Nirsevimab for All Infants in Preventing Respiratory Syncytial Virus (RSV): Related Hospitalizations and Costs in the Brazilian Private …

M Falavigna, SF Watanabe, J Santoro… - Value in …, 2023 - valueinhealthjournal.com
296 天前 - Objectives Respiratory syncytial virus (RSV) is the most common cause of lower
respiratory tract infection (LTRI) in infants and children worldwide and poses a significant …

[引用][C] … Prefusion F (RSVpreF) Maternal Vaccine for Prevention of Respiratory Syncytial Virus (RSV) Lower Respiratory Tract Illness (LRTI) Among Canadian Infants

A Goyette, A Averin, M Atwood, E Kutrieb… - Value in …, 2023 - valueinhealthjournal.com
296 天前 - … , and 39,127 outpatient clinic (OC) encounters due to RSV-… ), RSVpreF was projected
to reduce RSV-LRTI hospitalizations by … burden associated with RSV-LRTI among infants. …